These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26048639)

  • 1. Application of programmable bio-nano-chip system for the quantitative detection of drugs of abuse in oral fluids.
    Christodoulides N; De La Garza R; Simmons GW; McRae MP; Wong J; Newton TF; Smith R; Mahoney JJ; Hohenstein J; Gomez S; Floriano PN; Talavera H; Sloan DJ; Moody DE; Andrenyak DM; Kosten TR; Haque A; McDevitt JT
    Drug Alcohol Depend; 2015 Aug; 153():306-13. PubMed ID: 26048639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next Generation Programmable Bio-Nano-Chip System for On-Site Detection in Oral Fluids.
    Christodoulides N; De La Garza R; Simmons GW; McRae MP; Wong J; Newton TF; Kosten TR; Haque A; McDevitt JT
    J Drug Abuse; 2015 Nov; 1(1):1-6. PubMed ID: 26925466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid.
    Cone EJ; Clarke J; Tsanaclis L
    J Anal Toxicol; 2007 Oct; 31(8):424-33. PubMed ID: 17988455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The recovery of illicit drugs from oral fluid sampling devices.
    Dickson S; Park A; Nolan S; Kenworthy S; Nicholson C; Midgley J; Pinfold R; Hampton S
    Forensic Sci Int; 2007 Jan; 165(1):78-84. PubMed ID: 16621382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field Detection of Drugs of Abuse in Oral Fluid Using the Alere™ DDS®2 Mobile Test System with Confirmation by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS).
    Krotulski AJ; Mohr ALA; Friscia M; Logan BK
    J Anal Toxicol; 2018 Apr; 42(3):170-176. PubMed ID: 29301050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral fluid testing for drugs of abuse: positive prevalence rates by Intercept immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations.
    Cone EJ; Presley L; Lehrer M; Seiter W; Smith M; Kardos KW; Fritch D; Salamone S; Niedbala RS
    J Anal Toxicol; 2002; 26(8):541-6. PubMed ID: 12501910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugged Driving in Wisconsin: Oral Fluid Versus Blood.
    Edwards LD; Smith KL; Savage T
    J Anal Toxicol; 2017 Jul; 41(6):523-529. PubMed ID: 28830121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of drugs of abuse in oral fluid collection devices with purpose of external quality assessment schemes.
    Ventura M; Pichini S; Ventura R; Leal S; Zuccaro P; Pacifici R; de la Torre R
    Ther Drug Monit; 2009 Apr; 31(2):277-80. PubMed ID: 19307939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
    Crouch DJ; Walsh JM; Cangianelli L; Quintela O
    Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Substance abuse detection in substitution therapy : Oral fluid versus urine screening].
    Stein J; Geraedts M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1261-1268. PubMed ID: 28929198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral fluid is a viable alternative for monitoring drug abuse: detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with Methadone or Buprenorphine.
    Vindenes V; Yttredal B; Oiestad EL; Waal H; Bernard JP; Mørland JG; Christophersen AS
    J Anal Toxicol; 2011 Jan; 35(1):32-9. PubMed ID: 21219701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Drugs in Simultaneously Collected Samples of Oral Fluid and Blood.
    Bakke E; Høiseth G; Arnestad M; Gjerde H
    J Anal Toxicol; 2019 Apr; 43(3):228-232. PubMed ID: 30295809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance evaluation of on-site oral fluid drug screening devices in normal police procedure in Germany.
    Musshoff F; Hokamp EG; Bott U; Madea B
    Forensic Sci Int; 2014 May; 238():120-4. PubMed ID: 24699311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A field test of substance use screening devices as part of routine drunk-driving spot detection operating procedures in South Africa.
    Matzopoulos R; Lasarow A; Bowman B
    Accid Anal Prev; 2013 Oct; 59():118-24. PubMed ID: 23770390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of illicit drugs in oral fluid from drivers as biomarker for drugs in blood.
    Gjerde H; Langel K; Favretto D; Verstraete AG
    Forensic Sci Int; 2015 Nov; 256():42-5. PubMed ID: 26295911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of three rapid oral fluid test devices on the screening of multiple drugs of abuse including ketamine.
    Tang MHY; Ching CK; Poon S; Chan SSS; Ng WY; Lam M; Wong CK; Pao R; Lau A; Mak TWL
    Forensic Sci Int; 2018 May; 286():113-120. PubMed ID: 29574346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
    Davey J; Leal N; Freeman J
    Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of rapid point-of-collection oral fluid drug-testing devices.
    Walsh JM; Flegel R; Crouch DJ; Cangianelli L; Baudys J
    J Anal Toxicol; 2003 Oct; 27(7):429-39. PubMed ID: 14606995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.
    Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P
    Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection times of drugs of abuse in blood, urine, and oral fluid.
    Verstraete AG
    Ther Drug Monit; 2004 Apr; 26(2):200-5. PubMed ID: 15228165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.